Aluminum Company Settles Montana Pollution Cleanup Bill
Published Date: 7/7/2026
Notice
Summary
The Columbia Falls Aluminum Company (CFAC) will pay back $1.8 million for past pollution cleanup and cover future costs, which could total over $57 million, to clean up a hazardous site in Montana. In return, the government promises not to sue CFAC again for this pollution. The public has 30 days to share their thoughts on this cleanup deal.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
CFAC to Pay $1.8M Now and ~$57.6M Later
The Columbia Falls Aluminum Company (CFAC) agrees to reimburse the EPA $1,800,000.00 for past cleanup costs and to pay future response costs for the Columbia Falls site; EPA estimates the work required will cost $57,634,528.00. CFAC must complete all cleanup work required under the EPA Record of Decision issued in January 2025, and the United States and the State of Montana will provide covenants not to sue under CERCLA and CECRA in exchange.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160 — Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-13705 — Importer of Controlled Substances Application: Benuvia Operations, LLC.
Benuvia Operations, LLC wants to become an official importer of certain controlled substances like marijuana extract and psilocybin. People and companies involved with these drugs can share their thoughts or ask for a hearing by August 6, 2026. This move could shake up who gets to bring these substances into the U.S., so keep an eye on the deadline if you’re interested!
2026-13623 — United States et al. v. Live Nation Entertainment, Inc.; Proposed Final Judgment and Competitive Impact Statement
The government is making Live Nation and Ticketmaster play fair by breaking up some of their exclusive deals and letting artists, promoters, and venues use other ticket sellers. They’ll also cap fees, share data with artists, and sell some amphitheaters to boost competition. These changes start soon and will be watched closely to keep the music scene open and exciting for everyone.
2026-13580 — Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
Starting July 6, 2026, the DEA plans to temporarily put 7-hydroxymitragynine above a certain amount into Schedule I, meaning it’s treated like the most tightly controlled drugs. This affects anyone who makes, sells, studies, or even just has this substance, bringing strict rules and penalties. The move aims to keep people safe while the government figures out the long-term plan.
Previous / Next Documents
Previous: 2026-13718 — Agency Information Collection Activities; Tribal Revenue Allocation Plans
The Bureau of Indian Affairs wants to keep collecting info about how tribes share their money, making sure the process stays clear and easy. This affects tribal governments who submit these plans, and the agency is asking for your thoughts by September 8, 2026. No big changes or costs are planned, just a smooth renewal to keep things running right.
Next: 2026-13726 — Revisions to Financial Forms Reporting and Filing Requirements; Correction
The Federal Energy Regulatory Commission fixed a mistake in their June 24, 2026, announcement about updating financial reporting forms. They pushed back the deadline for reply comments from July 24 to September 22, 2026. This change affects companies that file these financial forms, giving them more time to share their thoughts—no extra costs involved, just a new timeline!